![Peter McNamara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter McNamara
Plus aucun poste en cours
Fortune : 2 M $ au 30/06/2026
Profil
Dr. Peter McNamara is a Chief Scientific Officer at Tectonic Therapeutic, Inc. Dr. McNamara was previously employed as a Chief Scientific Officer by AVROBIO, Inc., an Executive Director-Biotherapeutics & Biotechnology by Novartis Institute for Functional Genomics, Inc., and a Director-Pharmacology by Phenomix Corp.
He received his undergraduate degree from National University of Ireland Galway and a doctorate degree from National University of Ireland Galway.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,29 % | 30/06/2026 | 55 285 ( 0,29 % ) | 2 M $ | 30/06/2026 |
Postes actifs de Peter McNamara
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Peter McNamara
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Corporate Officer/Principal | 01/04/2021 |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Corporate Officer/Principal | 01/08/2005 |
| TECTONIC THERAPEUTIC, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Peter McNamara
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
National University of Ireland Galway
 National University of Ireland Galway Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
